Daniel MacLachlan
Chief Financial OfficerMr. Daniel MacLachlan, also known as Dan, has been Chief Financial Officer of Red Violet, Inc. since August 2017. Mr. MacLachlan served as the Chief Financial Officer of cogint since March 2016 and has over a decade of experience as the chief financial officer of data-driven technology companies. Mr. MacLachlan served as an Independent Director for Vapor Corp., a U.S.-based distributor and retailer of vaporizers, e-liquids and electronic cigarettes, from April 2015 through April 2016. From October 2014 until early February 2015, Mr. MacLachlan served as the Chief Financial Officer of TBO. Prior to TBO, Mr. MacLachlan served in the roles of Director of Finance and Chief Financial Officer for TRADS, after it acquired substantially all of the assets of TLO, through a 363 sale process in December 2013. Mr. MacLachlan served as Chief Financial Officer of Fluent from March 2016 until the Spin-off and brings over a decade of experience as the chief financial officer of data-driven technology companies. From October 2014 until February 2015, Mr. MacLachlan served as the Chief Financial Officer of IDI Holdings. Mr. MacLachlan was the Chief Financial Officer of TLO since its inception in 2009 to December 2013. From 2005 to 2009, Mr. MacLachlan served as the Chief Financial Officer of JARI Research Corporation (“JARI”), a partnership with the Mayo Clinic advancing proprietary cancer therapeutic technology using targeted radioactive therapy. Prior to JARI, Mr. MacLachlan served as a Special Agent in the Federal Bureau of Investigation (FBI) specializing in the criminal investigation of public corruption and civil rights violations.
Positions
- Company NameRed Violet, Inc.Stock CodeRDVTPositionChief Financial OfficerColleagues
